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Sudden deafness (SD) is a common otological
condition. In 1996, the otolaryngology branch of Chi-
nese Medical Association and the Editorial Board of
Chinese Journal of Otolaryngology published its re-
commended diagnosis and treatment standards for SD
(the“1996 standard”) in Shanghai. The standards de-
fine SD as sensorineural origin with unknown etiology.
The diagnosis criteria include sudden onset, absence of
clear precipitating causes, non-fluctuating sensorineu-
ral loss at middle or high frequencies, accompanying
tinnitus, vertigo, nausea and vomiting, no recurrent at-
tacks, and absence of damage to cranial nerves other
than the VIIIth cranial nerve. By the standards, the ef-
fect of complete recovery from SD corresponds to nor-
mal or pre-disease level hearing thresholds over the fre-
quency ranged from 250 to 4000 Hz; the effect of ex-
cellent treatment results represent a 30 dB or more im-
provement in the mean hearing threshold over the
above-mentioned frequency range; regain of useful
hearing is defined as mean threshold improvement
over the same frequency range between 15 and 30 dB;
and treatment resulting in less than 15 dB mean
threshold improvement is considered ineffective.
There have been a large number of reports on the
diagnosis and treatment of SD in the Chinese literature
in recent years. Many studies have focused on pharma-
cological agents that dilate blood vessels, improve mi-
crocirculation and/or reduce blood viscosity, as well as
anti-viral and neural nourishment agents. Other treat-
ments that have been studied including physical thera-
pies and hyperbaric oxygen therapies. The response
rate for these treatments averages around 80% with sig-
nificant variations between different treatments. Evalua-
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Abstract Objective To evaluate the current status of clinical studies on diagnosis and treatment of sudden
deafness (SD) in China by retrospective reviewing articles on SD published in Chinese journals in the past 5 years.
Special attention is given to whether the diagnosis and treatment standards established in 1996 by the otolaryngolo-
gy branch of Chinese Medical Association (the"1996 standard") were followed. Methods The terms of "Sudden
deafness" and "treatment" were used as the keywords in searching articles published between 2000 and 2004 in the
Chinese biomedicine literature database and Chinese journal network. Principles of evidence-based medicine were
applied in reviewing the articles. Results Two hundreds and thirty- four articles were identified, including 176 be-
tween 2000 and 2002 and 58 between 2003 and 2004. Among the 176 articles published between 2000 and 2002,
effects of medications were studies in 126 articles, of which only 26 (20.6% ) followed the"1996 standards".
Eighty-nine (70.6%) were reported based on controlled clinical trials (CCT) and 36 (28.5%) met the criteria of ran-
domized controlled trails (RCT). Of the 58 articles published between 2003 and 2004, drug effects were evaluated
in 25 articles, which were all based on the "1996 standards". However, there lacked placebo control, follow-up data
or statistical analysis in these papers. Only 6 articles reported side-effects from pharmacological treatment. Con⁃
clusions While a significant number of articles on SD were published in the past 5 years, the "1996 standards"
were followed only in a small number of them. The standards may not be appropriate in guiding research and need
to be modified for improved guidance to SD management. Multi-center, RCTs should be a crucial part in studies on
SD.
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tion of true treatment effects is difficult from these re-
ports. To understand the current state of diagnosis and
treatment of SD in China, it is of critical importance to
analyze the reported treatment methods and results in a
comparative manner. We have previously studied the lit-
erature data from 2000 to 2002. (Guo et al, 2004) In
the current work, we have included literature data from
2003 to 2004 for a study covering the entire period
from 2000 to 2004. Attention has been paid to whether
the“1996 Standards" have been followed in these stud-
ies.
Materials and methods
The terms of "sudden deafness" and "treatment"
were used as the key words in searching the Chinese bio-
medicine literature database and Chinese journal net
from 2000 to 2004. The following aspects of the articles
were analyzed: ① diagnostic and therapeutic protocols;
② study design; ③ selection of study subjects; ④ sam-
ple size;⑤ randomized controls;⑥ between-group com-
parison; ⑦ control techniques; ⑧ blinding methods; ⑨
criteria for treatment effects; ⑩ interventional proce-
dures.
Results
1. General results: Two hundred and thirty four articles
on SD treatment were identified. Of these, 176 were
published between 2000 and 2002, including 126 arti-
cles on pharmacological treatment effects and 50 on
correlation factors for prognosis and serum analysis.
Of the 58 articles published between 2003 and 2004,
25 studied drug therapy effects, while the rest were re-
view articles and studies on nursing issues or etiology
of SD. Average treatemnt effective rates in the 234 arti-
cles ranged from 60.3% to 94.5%.
2. Diagnostic and treatment effect judgment standards:
Most of these studies reported their criteria for judging
treatment effects, but the diagnostic criteria were much
less clear. Of the 126 articles on SD treatment pub-
lished between 2000 and 2002, only 26 (20.6%) based
their diagnostic criteria on the"1996 standards", and
38 ( 23.8% ) had either their unique diagnostic stan-
dards or borrowed diagnostic standards from other stud-
ies. In contrast, all 25 articles on drug effects published
between 2003 and 2004 noted that patient selection
was based on the "1996 Standards".
3. Study design: Of the 126 articles from 2000 to 2002,
89(70.6%) were controlled clinical trials (CCT), includ-
ing 36(28.6%) that described randomization methodolo-
gies consistent with randomized controlled
trails(RCT). In 70 articles, a particular drug was used
in addition to routine drug treatment protocols in the
test group for comparison to a control group receiving
only the routine protocol. Typical routine protocols in-
cluded prescription Dan Shen (a Chinese herbal extrac-
tion compound), cytochrome C, Dextran, cortical ste-
roids, adenosine triphosphate, etc, but they varied from
study to study. Agents studied in the test group in some
studies might be used in the control group in others. An
example is the prescription Dan Shen, which was stud-
ied in the test group in 6 studies but used in the control
group in another 24 studies. Average effective rate was
83.1±2.02% in the 6 studies where it was studied in the
test group and 54.3 ± 1.96% in the 24 studies where it
was used in the control group. The difference between
the two groups was statistically significant (p < 0.01).
4. Between-group comparison: Most of studies provid-
ed demographic and general medical information of
their patient groups, including the mean age, degree of
hearing loss and duration of disease, comparison be-
tween test and control groups, were ambiguous. None
of the 234 articles described statistical approaches for
between-group comparison.
5. Other issues: Placebo control was used in none of
the studies reviewed here. As only 6 studies reported
side-effects. All 234 papers lacked follow-up data.
Discussion
From analyzing the 234 articles, it becomes clear
that besides the large number of studies on SD and their
resultant achievements, there are obvious problems that
affect the quality of these studies. Only a small portion
of studies(28.5%) between 2000 and 2002 were RCTs,
which is seriously compromising their value in guiding
clinical practice. Evidence-based medicine requires that
clinical decision be based on reliable study evidence,
such as obtained from properly designed clinical re-
search and rigorous literature study. RCT is the pre-
ferred design for clinical research (Ruan et al, 1999),
which minimizes interference from the relative factors
between different researchers to ensure that findings
are reliable.
The majority(90%) of the 126 articles on SD treat-
ment published between 2000 and 2002 reported superi-
or treatment results in the test group over the control, al-
though contradictory conclusions were reported be-
tween studies. For example, the average effective rate
with prescription Dan-shen is 83.1% when studied in
the test group and 54.3% when used in the control, and
the difference is statistically significant. Vickers et al.
(Vickers et al, 1998) pointed out that publication bias
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existed in certain countries including China. Unusually
high proportions of positive results have been reported
in clinical research works published in Chinese academ-
ic journals. While diagnosis and therapy standards for
SD have been recommended since 1996, only 20.6% of
the SD related papers published between 2000 and
2002 based their diagnostic criteria on the standards, al-
though this improved significantly in papers published
between 2003 and 2004, of which all noting compli-
ance with the“1996 Standards”. Other factors that may
potentially affect treatment results including age, dura-
tion of disease, disease incidence, severity of symp-
toms and comorbidities. These factors need to be taken
into consideration when studying the etiology and treat-
ment effect in SD. When"etiology unknown" is used as
an inclusion criterion, it needs to be clearly defined to
avoid confusion in subject inclusion and difficulties in
cross-comparing studies.
The majority of reports on SD treatment focused
on pharmacological therapies. Treatment agents were
selected based on their pharmacological action and clin-
ical indications. For agents used to produce vasodila-
tion, microcirculation improvement and/or reduction in
blood viscosity, pre- and post-treatment laboratory tests
are important in both the test and control groups to veri-
fy treatment effects and to help understand the relation-
ship between the drugs and therapeutic effects. For anti-
viral medications, the relationship between the onset of
disease and viral symptoms should be established. If
the agent is used to affect blood supply to the cochlea, a
good understanding of factors that can change cochlear
blood supply is critical and the factors should be includ-
ed in the analysis. It is well known that prognosis in SD
can be influenced by multiple factors. Some SD pa-
tients may recover spontaneously without medical inter-
vention. All these can potentially complicate studies
aimed at evaluating treatment effects in SD. Other fac-
tors that can compromise the value of the 234 studies
are lack of use of placebo control and lack of statistical
analysis between groups in all 234 papers.
In a clinical study that involved medication trials,
it is important to report any side-effect or complica-
tions from the treatment, in addition to reporting treat-
ment results. While short-term results were reported in
most of the studied reports, few included long-term re-
sults. None of the 234 papers included follow-up data.
Evidence based medicine warns against conclusions
based on partial, temporary or superficial results. Re-
sults from large sample size, long-term follow-up, and
randomized controlled trials are encouraged for mean-
ingful interpretation (Kirk, 2001).
Considering the current state of clinical studies on
SD and the many challenges of SD poses to clinical re-
searchers regarding its etiology, prognosis and possibili-
ty of spontaneous recovery, the authors make the fol-
lowing recommendations for future studies on the diag-
nosis and treatment of SD: 1. Multi-centric, prospec-
tive, randomized and blind controlled clinical trails
should be considered in study design. 2. Pathophysio-
logical mechanisms should be taken into account when
formulating treatment plans. Appropriate management
of blood pressure and cholesterol levels, completed
with pre- and post-treatment rheological tests, should
be considered for patient with hypertension and hyperli-
podemia. Blood rheological study, in addition to audio-
metric evaluation, should be an important part of treat-
ment effects evaluation. Liu chan(Liu, 1997) believes
that treatments of diseases caused by viral infection and
circulatory disorders should be different. Selection of
treatment agents should therefore be the result of a thor-
ough study of potential etiologies. 3. Now may be the
time to revise the 10 years old of "1996 Standards",
which may have been too simple and general to provide
much meaningful guidance in SD study. Its diagnostic
criteria and the guidelines for reporting treatment re-
sults are difficult to follow. Application of the standards
in SD study should not be affected by the concerns at
the time of their compilation regarding limited resourc-
es at primary care facilities. The focal points in revision
of the "standards" may include quantitative measure-
ment of hearing loss, detailed diagnosis and therapy
standards, and guidelines for treatment indications and
protocols. The goal should be to increase their value in
guiding clinical practice and research.
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